tiprankstipranks
Zhejiang Taimei Medical Technology Co Ltd Class H (HK:2576)
:2576
Hong Kong Market
2576
Zhejiang Taimei Medical Technology Co Ltd Class H
RESEARCH TOOLSreports
Want to see HK:2576 full AI Analyst Report?

Zhejiang Taimei Medical Technology Co Ltd Class H (2576) Ratios

0 Followers

Zhejiang Taimei Medical Technology Co Ltd Class H Ratios

HK:2576's free cash flow for Q1 2024 was ¥0.37. For the 2024 fiscal year, HK:2576's free cash flow was decreased by ¥ and operating cash flow was ¥-0.89. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.47 4.47 5.05 3.71 4.24
Quick Ratio
 4.47 4.47 5.05 3.71 4.24
Cash Ratio
 1.91 1.91 1.09 1.45 1.70
Solvency Ratio
 -0.06 -0.06 -0.50 -0.73 -0.81
Operating Cash Flow Ratio
 -0.12 -0.12 -0.69 -0.98 -0.84
Short-Term Operating Cash Flow Coverage
 -0.82 -0.82 -20.15 -25.91 -9.25
Net Current Asset Value
¥ 1.10B¥ 1.10B¥ 1.13B¥ 923.63M¥ 1.22B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.02 0.02 0.04
Debt-to-Equity Ratio
 0.05 0.05 0.03 0.03 0.06
Debt-to-Capital Ratio
 0.05 0.05 0.03 0.03 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.39 1.39 1.37 1.48 1.39
Debt Service Coverage Ratio
 -0.86 -0.86 -16.47 -20.22 -9.52
Interest Coverage Ratio
 -75.79 -75.79 -347.25 -277.14 -165.16
Debt to Market Cap
 0.02 0.02 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.11 0.11 0.06 0.05 0.15
Net Debt to EBITDA
 13.43 13.43 1.61 1.61 1.61
Profitability Margins
Gross Profit Margin
42.44%42.44%40.81%31.23%33.76%
EBIT Margin
-12.32%-12.32%-39.31%-61.93%-76.45%
EBITDA Margin
-8.42%-8.42%-32.07%-52.86%-66.34%
Operating Profit Margin
-12.32%-12.32%-45.80%-69.20%-80.62%
Pretax Profit Margin
-9.89%-9.89%-39.45%-62.18%-76.94%
Net Profit Margin
-8.36%-8.36%-38.94%-60.51%-75.18%
Continuous Operations Profit Margin
-9.89%-9.89%-39.45%-62.18%-76.94%
Net Income Per EBT
84.51%84.51%98.71%97.31%97.71%
EBT Per EBIT
80.31%80.31%86.12%89.86%95.44%
Return on Assets (ROA)
-2.68%-2.68%-13.56%-24.00%-22.62%
Return on Equity (ROE)
-3.66%-3.72%-18.54%-35.45%-31.52%
Return on Capital Employed (ROCE)
-5.00%-5.00%-19.56%-36.49%-30.88%
Return on Invested Capital (ROIC)
-4.78%-4.78%-19.24%-35.64%-29.50%
Return on Tangible Assets
-2.78%-2.78%-14.07%-25.40%-23.67%
Earnings Yield
-1.85%-2.08%-9.47%-7.42%-9.07%
Efficiency Ratios
Receivables Turnover
 2.48 2.48 2.94 3.22 3.36
Payables Turnover
 2.76 2.76 3.26 5.57 7.56
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 22.35 22.35 14.71 13.88 6.47
Asset Turnover
 0.32 0.32 0.35 0.40 0.30
Working Capital Turnover Ratio
 0.43 0.43 0.51 0.51 0.44
Cash Conversion Cycle
 14.86 14.86 12.33 47.98 60.26
Days of Sales Outstanding
 147.17 147.17 124.17 113.47 108.54
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 132.31 132.31 111.85 65.49 48.28
Operating Cycle
 147.17 147.17 124.17 113.47 108.54
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.07 -0.07 -0.36 -0.63 -0.59
Free Cash Flow Per Share
 -0.08 -0.08 -0.37 -0.64 -0.64
CapEx Per Share
 <0.01 <0.01 0.01 0.02 0.05
Free Cash Flow to Operating Cash Flow
 1.10 1.10 1.03 1.03 1.09
Dividend Paid and CapEx Coverage Ratio
 -10.45 -10.45 -32.73 -37.06 -11.66
Capital Expenditure Coverage Ratio
 -10.45 -10.45 -32.73 -37.06 -11.66
Operating Cash Flow Coverage Ratio
 -0.64 -0.64 -5.80 -12.26 -4.04
Operating Cash Flow to Sales Ratio
 -0.08 -0.08 -0.37 -0.61 -0.60
Free Cash Flow Yield
-1.91%-2.15%-9.15%-7.72%-7.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -54.16 -48.05 -10.56 -13.47 -11.03
Price-to-Sales (P/S) Ratio
 4.53 4.02 4.11 8.15 8.29
Price-to-Book (P/B) Ratio
 2.01 1.79 1.96 4.78 3.48
Price-to-Free Cash Flow (P/FCF) Ratio
 -52.40 -46.47 -10.93 -12.95 -12.74
Price-to-Operating Cash Flow Ratio
 -57.40 -50.92 -11.24 -13.30 -13.83
Price-to-Earnings Growth (PEG) Ratio
 -0.54 0.59 0.28 0.83 0.79
Price-to-Fair Value
 2.01 1.79 1.96 4.78 3.48
Enterprise Value Multiple
 -40.36 -34.28 -11.21 -13.80 -10.89
Enterprise Value
 1.70B 1.44B 1.98B 4.18B 3.97B
EV to EBITDA
 -40.36 -34.28 -11.21 -13.80 -10.89
EV to Sales
 3.40 2.89 3.60 7.30 7.22
EV to Free Cash Flow
 -39.32 -33.39 -9.56 -11.60 -11.10
EV to Operating Cash Flow
 -43.08 -36.59 -9.83 -11.91 -12.05
Tangible Book Value Per Share
 2.02 2.02 2.09 1.72 2.32
Shareholders’ Equity Per Share
 1.99 1.99 2.05 1.75 2.34
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 >-0.01 0.00
Revenue Per Share
 0.89 0.89 0.98 1.02 0.98
Net Income Per Share
 -0.07 -0.07 -0.38 -0.62 -0.74
Tax Burden
 0.85 0.85 0.99 0.97 0.98
Interest Burden
 0.80 0.80 1.00 1.00 1.01
Research & Development to Revenue
 0.15 0.15 0.16 0.30 0.43
SG&A to Revenue
 0.39 0.39 0.69 0.42 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.23 0.02 0.16
Income Quality
 0.78 0.78 0.93 0.92 0.78
Currency in CNY